Trademark Search in Canada

QUILLIVANT

View On IC.GC.CA

REGISTERED

on 1 Jul 2019

Last Applicant/ Owned by

NEXTWAVE PHARMACEUTICALS INC.

2033 Route 130 Suite DMonmouth Junction, NJ 08852

Serial Number

1846985 filed on 12^th Jul 2017

Registration Number

TMA1033944 registered on 1^st Jul 2019

Registration expiry Date

1^st Jul 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

QUILLIVANT

Trademark usage description

oral pharmaceutical preparations for the extended relief of nervous diseases and disorders, namely, psychiatric diseases and brain disorders, namely, Read More

Classification Information

Class [005]
Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders namely psychiatric diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder

Classification kind code

Mark Details

Serial Number

1846985

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 1^st Mar 2019	Allowed
Submitted for opposition 51 on 1^st Mar 2019	Allowance Notice Sent
Submitted for opposition 42 on 14^th Nov 2018	Advertised
Submitted for opposition 26 on 25^th Oct 2018	Approved
Submitted for opposition 27 on 5^th Sept 2018	Approval Notice Sent
Submitted for opposition 22 on 26^th Jun 2018	Search Recorded
Submitted for opposition 20 on 26^th Jun 2018	Examiner's First Report
Submitted for opposition 31 on 18^th Jul 2017	Formalized
Submitted for opposition 1 on 13^th Jul 2017	Created
Submitted for opposition 30 on 12^th Jul 2017	Filed